Cisapride in chronic dyspepsia: Results of a double-blind, placebo-controlled trial

Scandinavian Journal of Gastroenterology

Volumn 28, Issue S195, 1993, Pages 11-14

  Chung, J M ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Chronic dyspepsia; Cisapride

Indexed keywords

CISAPRIDE; PLACEBO; PIPERIDINE DERIVATIVE;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TOLERANCE; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; PRIORITY JOURNAL; STOMACH EMPTYING; ADOLESCENT; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GASTROINTESTINAL MOTILITY; HOSPITALIZATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHRONIC DISEASE; CISAPRIDE; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; MALE; PIPERIDINES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0027154981     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529309098323     Document Type: Article

References (27)

1. Definitions of dyspepsia
2. Drug treatment of functional dyspepsia
3. Chronic gastritis and gastric function
4. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying
5. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders
6. Stimulation of gastroduodenal motor activity: dopaminergic and cholinergic modulation
7. Clinical pharmacological evidence for cisapride's lack of antidopaminergic or direct cholinergic properties
8. Safety profile of cisapride
9. Placebo-controlled study of the effect of cisapride on the lesions and symptoms of reflux oesophagitis
10. Impaired transit of chyme in chronic intestinal pseudo-obstruction. Correction by cisapride
11. Cisapride in the treatment of functional non-ulcer dyspepsia. A double-blind, placebo-controlled, crossover trial
12. Cisapride in esophagitis. A placebo-controlled trial
13. Effect of cisapride on gastric and esophageal emptying in insulin dependent diabetes mellitus
14. Colon motility and coloanal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride
15. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial
16. Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients
17. Effect of cisapride and metoclopramide on the lower esophageal motility pressure. A pressure and pH-metric study
18. Comparative study on cisapride's versus metoclopramide's effect on esophageal motility
19. Mechanism of action of cisapride: evidence for regional difference in the gastrointestinal tract
20. Acute effect of the gastrokinetics cisapride and metoclopramide on the gastric emptying function in patients with the early satiety syndrome
21. Measurement of gastric emptying in dyspeptic patients; effect of a new gastrokinetic agent (cisapride)
22. Motor-stimulating properties of cisapride on isolated gastrointestinal preparation of the guinea pig
23. Effect of cisapride on gastric emptying in dyspeptic patients
24. Therapy of chronic functional dyspepsia: multicenter crossover study of cisapride and placebo
25. Therapeutic doses of cisapride in the treatment of chronic functional dyspepsia
26. When and how to investigate the dyspeptic patient
27. Therapeutic trial in dyspepsia: its role in the primary care setting